These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8179963)

  • 41. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
    Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
    Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes.
    Malim MH; Hauber J; Fenrick R; Cullen BR
    Nature; 1988 Sep; 335(6186):181-3. PubMed ID: 3412474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of the nef and tat genes of the human immunodeficiency virus type I on rodent cells in vivo and in vitro].
    Shugurova IM; Andreeva LE; Dubovaia VI; Zueva LA; Serova IA; Tarantul VZ
    Genetika; 1997 Sep; 33(9):1202-8. PubMed ID: 9445814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.
    Laube LS; Burrascano M; Dejesus CE; Howard BD; Johnson MA; Lee WT; Lynn AE; Peters G; Ronlov GS; Townsend KS
    Hum Gene Ther; 1994 Jul; 5(7):853-62. PubMed ID: 7981310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
    Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes.
    Karn J
    Curr Opin Immunol; 1991 Aug; 3(4):526-36. PubMed ID: 1755979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression.
    Srinivasakumar N; Schuening F
    J Virol; 2000 Jul; 74(14):6659-68. PubMed ID: 10864682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent.
    Winslow BJ; Trono D
    J Virol; 1993 Apr; 67(4):2349-54. PubMed ID: 8445733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational development of a HIV-1 gene therapy vector.
    Anson DS; Fuller M
    J Gene Med; 2003 Oct; 5(10):829-838. PubMed ID: 14533191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of a safe and efficient retrovirus packaging cell line.
    Markowitz D; Goff S; Bank A
    Adv Exp Med Biol; 1988; 241():35-40. PubMed ID: 3223411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.
    Miura T; Shibata R; Adachi A; Kuwata T; Chen J; Jin M; Ido E; Hayami M
    Arch Virol; 1996; 141(1):31-41. PubMed ID: 8629949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human cell lines stably expressing HIV env and tat gene products.
    Sosa MA; DeGasperi R; Fazely F; Ruprecht RM
    Biochem Biophys Res Commun; 1989 May; 161(1):305-11. PubMed ID: 2543412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A multigene lentiviral vector system based on differential splicing.
    Zhu Y; Planelles V
    Methods Mol Med; 2003; 76():433-48. PubMed ID: 12526178
    [No Abstract]   [Full Text] [Related]  

  • 58. Construction and characterization of retroviral vectors for interleukin-2 gene therapy.
    Fakhrai H; Shawler DL; Van Beveren C; Lin H; Dorigo O; Solomon MJ; Gjerset RA; Smith L; Bartholomew RM; Boggiano CA; Gold DP; Sobol RE
    J Immunother; 1997 Nov; 20(6):437-48. PubMed ID: 9409449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accurate and differential quantitation of HIV-1 tat, rev and nef mRNAs by competitive PCR.
    Merzouki A; Mo T; Vellani N; Pattullo A; Estable M; O'Shaughnessy M; Tsoukas C; Cassol S
    J Virol Methods; 1994 Dec; 50(1-3):115-28. PubMed ID: 7714034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.